Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
These drugs may raise levels of insulin-like growth factor 1 (IGF-1)
Mounjaro (tirzepatide) is a once-weekly injectable medication that works with your bodys natural hormones to reduce appetite and help you feel full longer
While the evidence suggests a potential increase in risk, it is essential to approach this information with a nuanced understanding, recognizing that individual patient factors play a significant role
Compounded tirzepatide has not been tested in the same controlled trials for safety or efficacy in weight loss
Here's what we're seeing: Injectable May Be Easier Initially If your plan covers injectable Wegovy but hasn't added the pill yet, consider starting with the injection